{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T04:54:49Z","timestamp":1790830489142,"version":"4.1.0"},"reference-count":42,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,9,9]],"date-time":"2026-09-09T00:00:00Z","timestamp":1788912000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100007723","name":"Takeda Pharmaceuticals USA Inc","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007723","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Affective Disorders"],"published-print":{"date-parts":[[2026,12]]},"DOI":"10.1016\/j.jad.2026.122429","type":"journal-article","created":{"date-parts":[[2026,8,28]],"date-time":"2026-08-28T13:40:07Z","timestamp":1787924407000},"page":"122429","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Real-world treatment patterns and persistent symptoms in adults with depression undergoing antidepressant treatment"],"prefix":"10.1016","volume":"415","author":[{"given":"Yiyan","family":"Liu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bertha","family":"de los Santos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sudhakar","family":"Manne","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vivek","family":"Gandhi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mei","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Martin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jad.2026.122429_bb0005","first-page":"1","article-title":"Practice guideline for the treatment of patients with major depressive disorder","volume":"167","author":"American Psychiatric Association","year":"2010","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.jad.2026.122429_bb0010","series-title":"Diagnostic and Statistical Manual of Mental Disorders","author":"American Psychiatric Association","year":"2022"},{"key":"10.1016\/j.jad.2026.122429_bb0015","author":"American Psychological Association"},{"key":"10.1016\/j.jad.2026.122429_bb0020","series-title":"StatPearl","article-title":"Major depressive disorder","author":"Bains","year":"2023"},{"key":"10.1016\/j.jad.2026.122429_bb0025","author":"Center for Behavioral Health Statistics and Quality, Substance Abuse and Mental Health Services Administration"},{"issue":"8","key":"10.1016\/j.jad.2026.122429_bb0030","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1176\/appi.ps.201800094","article-title":"Predicting barriers to treatment for depression in a U.S. national sample: a cross-sectional, proof-of-concept study","volume":"69","author":"Chekroud","year":"2018","journal-title":"Psychiatr. Serv."},{"issue":"1","key":"10.1016\/j.jad.2026.122429_bb0035","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1038\/s41398-025-03463-8","article-title":"Depression and health outcomes: an umbrella review of systematic reviews and meta-analyses of observational studies","volume":"15","author":"Chen","year":"2025","journal-title":"Transl. Psychiatry"},{"issue":"6","key":"10.1016\/j.jad.2026.122429_bb0040","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.1017\/S0033291710001911","article-title":"Presence of individual (residual) symptoms during depressive episodes and periods of remission: a 3-year prospective study","volume":"41","author":"Conradi","year":"2011","journal-title":"Psychol. Med."},{"issue":"5","key":"10.1016\/j.jad.2026.122429_bb0045","doi-asserted-by":"crossref","first-page":"1860","DOI":"10.1007\/s12325-024-02817-w","article-title":"The humanistic and economic burden associated with major depressive disorder: a retrospective cross-sectional analysis","volume":"41","author":"Culpepper","year":"2024","journal-title":"Adv. Ther."},{"key":"10.1016\/j.jad.2026.122429_bb0050","doi-asserted-by":"crossref","DOI":"10.1186\/s12991-020-00306-2","article-title":"How to improve adherence to antidepressant treatments in patients with major depression: a psychoeducational consensus checklist","volume":"19","author":"Dell\u2019Osso","year":"2020","journal-title":"Ann. Gen. Psychiatry"},{"issue":"1","key":"10.1016\/j.jad.2026.122429_bb0055","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1186\/s12888-025-06518-8","article-title":"Trajectories of pharmacological therapies for treatment-resistant depression: a longitudinal study","volume":"25","author":"DiBello","year":"2025","journal-title":"BMC Psychiatry"},{"issue":"3","key":"10.1016\/j.jad.2026.122429_bb0060","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1176\/appi.ajp.2007.06111868","article-title":"Difference in treatment outcome in outpatients with anxious versus nonanxious depression: a STAR*D report","volume":"165","author":"Fava","year":"2008","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.jad.2026.122429_bb0065","article-title":"Depression in primary care: part 1\u2014screening and diagnosis","volume":"365","author":"Ferenchick","year":"2019","journal-title":"BMJ"},{"issue":"1","key":"10.1016\/j.jad.2026.122429_bb0070","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1186\/s12991-023-00480-z","article-title":"Discontinuation of antidepressant treatment: a retrospective cohort study on more than 20,000 participants","volume":"22","author":"Garcia-Marin","year":"2023","journal-title":"Ann. Gen. Psychiatry"},{"issue":"1","key":"10.1016\/j.jad.2026.122429_bb0075","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1186\/s12888-017-1385-0","article-title":"Treatment patterns, healthcare resource utilization, and costs following first-line antidepressant treatment in major depressive disorder: a retrospective US claims database analysis","volume":"17","author":"Gauthier","year":"2017","journal-title":"BMC Psychiatry"},{"issue":"1","key":"10.1016\/j.jad.2026.122429_bb0080","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1136\/bmjment-2023-300827","article-title":"Treatments for partial remission of major depressive disorder: a systematic review and meta-analysis","volume":"26","author":"G\u00fclpen","year":"2023","journal-title":"BMJ Ment. Health"},{"key":"10.1016\/j.jad.2026.122429_bb0085","author":"HealthVerity"},{"key":"10.1016\/j.jad.2026.122429_bb0090","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.npbr.2020.03.002","article-title":"Real-world patient experience with sexual dysfunction and antidepressant use in patients with self-reported depression: a cross-sectional survey study","volume":"36","author":"Jacobsen","year":"2020","journal-title":"Neurol. Psychiatry Brain Res."},{"issue":"3","key":"10.1016\/j.jad.2026.122429_bb0095","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1007\/s40801-022-00316-4","article-title":"Treatment patterns during major depressive episodes among patients with major depressive disorder: a retrospective database analysis","volume":"9","author":"Jain","year":"2022","journal-title":"Drugs Real World Outcomes"},{"issue":"4","key":"10.1016\/j.jad.2026.122429_bb0100","doi-asserted-by":"crossref","first-page":"440","DOI":"10.4306\/pi.2016.13.4.440","article-title":"Times to discontinue antidepressants over 6 months in patients with major depressive disorder","volume":"13","author":"Jung","year":"2016","journal-title":"Psychiatry Investig."},{"issue":"1","key":"10.1016\/j.jad.2026.122429_bb0105","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1186\/s12888-019-2418-7","article-title":"Treatment patterns and sequences of pharmacotherapy for patients diagnosed with depression in the United States: 2014 through 2019","volume":"20","author":"Kern","year":"2020","journal-title":"BMC Psychiatry"},{"issue":"1","key":"10.1016\/j.jad.2026.122429_bb0110","doi-asserted-by":"crossref","DOI":"10.1038\/s41398-019-0460-3","article-title":"Prognosis and improved outcomes in major depression: a review","volume":"9","author":"Kraus","year":"2019","journal-title":"Transl. Psychiatry"},{"issue":"1","key":"10.1016\/j.jad.2026.122429_bb0115","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1186\/s12888-024-05915-9","article-title":"Factors influencing the tendency of residual symptoms in patients with depressive disorders: a longitudinal study","volume":"24","author":"Li","year":"2024","journal-title":"BMC Psychiatry"},{"issue":"5","key":"10.1016\/j.jad.2026.122429_bb0120","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1080\/00325481.2023.2189868","article-title":"Considerations when selecting an antidepressant: a narrative review for primary care providers treating adults with depression","volume":"135","author":"Montano","year":"2023","journal-title":"Postgrad. Med."},{"key":"10.1016\/j.jad.2026.122429_bb0125","author":"National Institute of Mental Health"},{"issue":"1","key":"10.1016\/j.jad.2026.122429_bb0130","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1017\/S0033291709006011","article-title":"Residual symptoms after remission of major depressive disorder with citalopram and risk of relapse: a STAR*D report","volume":"40","author":"Nierenberg","year":"2010","journal-title":"Psychol. Med."},{"key":"10.1016\/j.jad.2026.122429_bb0135","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1016\/j.jad.2022.10.034","article-title":"Longitudinal study to assess antidepressant treatment patterns and outcomes in individuals with depression in the general population","volume":"321","author":"Ohayon","year":"2023","journal-title":"J. Affect. Disord."},{"key":"10.1016\/j.jad.2026.122429_bb0140","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/j.jad.2022.07.009","article-title":"Residual cognitive and psychosocial functional impairment in outpatients in Greece who responded to conventional antidepressant monotherapy treatments for major depressive disorder (MDD)","volume":"314","author":"Papalexi","year":"2022","journal-title":"J. Affect. Disord."},{"issue":"5","key":"10.1016\/j.jad.2026.122429_bb0145","doi-asserted-by":"crossref","first-page":"350","DOI":"10.7326\/M15-2570","article-title":"Nonpharmacologic versus pharmacologic treatment of adult patients with major depressive disorder: a clinical practice guideline from the American College of Physicians","volume":"164","author":"Qaseem","year":"2016","journal-title":"Ann. Intern. Med."},{"issue":"2","key":"10.1016\/j.jad.2026.122429_bb0150","doi-asserted-by":"crossref","first-page":"239","DOI":"10.7326\/M22-2056","article-title":"Nonpharmacologic and pharmacologic treatments of adults in the acute phase of major depressive disorder: a living clinical guideline from the American College of Physicians","volume":"176","author":"Qaseem","year":"2023","journal-title":"Ann. Intern. Med."},{"issue":"10","key":"10.1016\/j.jad.2026.122429_bb0155","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1001\/jamapsychiatry.2024.1778","article-title":"Heterogeneity in antidepressant treatment and major depressive disorder outcomes among clinicians","volume":"81","author":"Rathnam","year":"2024","journal-title":"JAMA Psychiatry"},{"issue":"10","key":"10.1016\/j.jad.2026.122429_bb0160","doi-asserted-by":"crossref","first-page":"2029","DOI":"10.1017\/S0033291713002535","article-title":"Cognitive impairment in depression: a systematic review and meta-analysis","volume":"44","author":"Rock","year":"2014","journal-title":"Psychol. Med."},{"issue":"1","key":"10.1016\/j.jad.2026.122429_bb0165","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1186\/s12888-025-06751-1","article-title":"Antidepressant-associated sexual dysfunction in outpatients","volume":"25","author":"Safak","year":"2025","journal-title":"BMC Psychiatry"},{"issue":"1","key":"10.1016\/j.jad.2026.122429_bb0170","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1186\/s12888-023-04612-3","article-title":"Sex differences in residual somatic symptoms in patients with first-episode depression after acute-phase treatment","volume":"23","author":"Shi","year":"2023","journal-title":"BMC Psychiatry"},{"issue":"3","key":"10.1016\/j.jad.2026.122429_bb0175","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1007\/s00406-020-01216-w","article-title":"Fatigue and brain arousal in patients with major depressive disorder","volume":"271","author":"Surova","year":"2021","journal-title":"Eur. Arch. Psychiatry Clin. Neurosci."},{"issue":"1","key":"10.1016\/j.jad.2026.122429_bb0180","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1176\/appi.ajp.163.1.28","article-title":"Evaluation of outcomes with citalopram for depression using measurement-based care in STAR*D: implications for clinical practice","volume":"163","author":"Trivedi","year":"2006","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.jad.2026.122429_bb0185","series-title":"VA\/DoD Clinical Practice Guideline for the Management of Major Depressive Disorder. Version 4.0","author":"US Department of Veterans Affairs and Department of Defense","year":"2022"},{"issue":"6","key":"10.1016\/j.jad.2026.122429_bb0190","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1007\/s11920-007-0061-3","article-title":"The STAR*D Project results: a comprehensive review of findings","volume":"9","author":"Warden","year":"2007","journal-title":"Curr. Psychiatry Rep."},{"issue":"Suppl. 2","key":"10.1016\/j.jad.2026.122429_bb0195","doi-asserted-by":"crossref","first-page":"9","DOI":"10.4088\/JCP.12084su1c.02","article-title":"Residual symptoms and relapse: mood, cognitive symptoms, and sleep disturbances","volume":"74","author":"Zajecka","year":"2013","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.jad.2026.122429_bb0200","doi-asserted-by":"crossref","DOI":"10.1016\/j.neubiorev.2022.104532","article-title":"Sleep disorders and non-sleep circadian disorders predict depression: a systematic review and meta-analysis of longitudinal studies","volume":"134","author":"Zhang","year":"2022","journal-title":"Neurosci. Biobehav. Rev."},{"key":"10.1016\/j.jad.2026.122429_bb0205","article-title":"The prevalence and clinical correlation factors of cognitive impairment in patients with major depressive disorder hospitalized during the acute phase","volume":"15","author":"Zhao","year":"2024","journal-title":"Front. Psychol."},{"issue":"11-a suppl","key":"10.1016\/j.jad.2026.122429_bb0210","first-page":"S2","article-title":"Economic burden and antidepressant treatment patterns among patients with major depressive disorder in the United States","volume":"28","author":"Zhu","year":"2022","journal-title":"J. Manag. Care Spec. Pharm."}],"container-title":["Journal of Affective Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165032726012826?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165032726012826?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T03:54:47Z","timestamp":1790826887000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0165032726012826"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,12]]},"references-count":42,"alternative-id":["S0165032726012826"],"URL":"https:\/\/doi.org\/10.1016\/j.jad.2026.122429","relation":{},"ISSN":["0165-0327"],"issn-type":[{"value":"0165-0327","type":"print"}],"subject":[],"published":{"date-parts":[[2026,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Real-world treatment patterns and persistent symptoms in adults with depression undergoing antidepressant treatment","name":"articletitle","label":"Article Title"},{"value":"Journal of Affective Disorders","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jad.2026.122429","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Takeda Pharmaceuticals USA Inc. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"122429"}}